Enliven Therapeutics
ELVN
#4112
Rank
C$4.34 B
Marketcap
C$59.24
Share price
2.09%
Change (1 day)
107.97%
Change (1 year)

Enliven Therapeutics (ELVN) - Total debt

Total debt on the balance sheet as of June 2026 : C$0.85 Million

According to Enliven Therapeutics's latest financial reports the company's total debt is C$0.85 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Enliven Therapeutics - Total debt on balance sheet (from 2021 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$0.54 M
2024-12-31N/A-100%
2023-12-31C$0.44 M1.38%
2022-12-31C$0.43 M116.3%
2021-12-31C$0.2 M51.35%
2020-12-31C$0.13 M